Patents (1329 Stem Cell Patents)

Patents

Order by:
<< | < | 121 122 123 124 125 126 127 128 129 | > | >>


Liver reserve cells

Patent Number: 5559022

Liver stem cells are very interesting to study, in part because of the very potent regenerative ability of the liver. In this patent a type of liver stem cell is claimed called the "liver reserve cell". These cells are characterized by ability to be stained by methylene blue and Azure A, adherence, multinucleation, ability to differentated, and specific density on percoll.

Inventors: Naughton, Brian A. (El Cajon, CA); Sibanda, Benson (Oceanside, CA)
Assignee: Advanced Tissue Sciences, Inc. (La Jolla, CA)
Date of First Priority Issue: Friday October 9th, 1992

Hematopoietic stem cell specific gene expression

Patent Number: 5556954

This patent covers the promoter for CD34. CD34 is a classical marker of stem cells, not only of the hematopoietic type but also of the hepatic type. CD34 is highly glycosylated and acts as an adhesion molecule. Mice that are knocked out for CD34 still have hematopoiesis, however the stem cells to not migrate...

Inventors: Burn, Timothy C. (Bedford, MA); Satterthwaite, Anne B. (Brighton, MA); Tenen, Daniel G. (Boston, MA)
Assignee: Beth Israel Hospital Boston Association (Boston, MA)
Date of First Priority Issue: Thursday February 13th, 1992

Methods of culturing and modulating the growth of hair follicular stem cells

Patent Number: 5556783

This patent covers methods of expanding stem cells derived from the hair follicle. One of the methods of expanding hair follicle stem cells is through growing then on 3T3 fibroblasts. Hair stem cells are somewhat similar to mesenchymal stem cells and may be useful for a wide variety of applications in addition to hair replacement.

Inventors: Lavker, Robert M. (Malvern, PA); Sun, Tung-Tien (Scarsdale, NY); Yang, Jing-Shan (New York, NY)
Assignee: Trustees of Univ. of Penna (Philadelphia, PA) New York Univ. (New York, NY)
Date of First Priority Issue: Wednesday March 27th, 1991

Method for implanting encapsulated cells in a host

Patent Number: 5550050

Microencapsulation allows delivery of immunologically incompatible cells to a recipient. The technology of microencapsulation has been used clinically for a variety of uses, including administration of cell therapy ranging from neurons to islets. The use of embryonic stem cells may require encapsulation so has to not only overcome the allogeneic barriers, but also to prevent growth and...

Inventors: Holland, Laura M. (Providence, RI); Hammang, Joseph P. (Barrington, RI); Rudnick, Seth A. (Barrington, RI); Lysaght, Michael J. (E. Greenwich, RI); Dionne, Keith E. (Rehoboth, MA)
Assignee: CytoTherapeutics, Inc. (Providence, RI)
Date of First Priority Issue: Friday April 15th, 1994

Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo

Patent Number: 5549674

This patent covers an artificial kidney system designed in a manner so as to combine hollow fiber technology with living, fresh endothelial cells. This patent does mention that in some embodiments stem cells may be used for providing the necessary cells. Various artificial kidneys have been designed and the author of this patent has actually been involved in their clinical development...

Inventors: Humes, H. David (Ann Arbor, MI); Cieslinski, Deborah A. (Ann Arbor, MI)
Assignee: The Regents of The University of Michigan (Ann Arbor, MI)
Date of First Priority Issue: Monday March 2nd, 1992

Three-dimensional bone marrow cell and tissue culture system

Patent Number: 5541107

In this patent regarding bone marrow stem cell culture, Advanced Tissue Sciences continues their tour de force in three dimensional culture IP, through covering the use of three dimensional cultures for expanding bone marrow stem cells. Specifically, the patent teaches that stromal cells and a three dimensional matrix can be used for expansion of hematopoietic...

Inventors: Naughton, Gail K. (Groton, VT); Naughton, Brian A. (Groton, VT)
Assignee: Advanced Tissue Sciences, Inc. (La Jolla, CA)
Date of First Priority Issue: Friday April 18th, 1986

Inducing granulocyte production or B cell production in peripheral blood by TGF-.beta.

Patent Number: 5529982

TGF-beta is a cytokine with numerous anti-inflammatory functions. The importance of TGF-beta at controlling inflammation is seen not only in its ability to prevent autoimmunity in several animal models, but also by the fact that tumor cells secrete large quantities of it in order to escape immune-mediated killing. This patent teaches...

Inventors: Carlino, Joseph (San Leandro, CA); Singh, Naina (Santa Clara, CA); Ellingsworth, Larry (San Jose, CA)
Assignee: Celtrix Pharmaceuticals, Inc. (Santa Clara, CA)
Date of First Priority Issue: Tuesday August 6th, 1985

Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF

Patent Number: 5527776

This patent teaches that IGF-1 together with IGF Binding Protein-3 (IGFBP-3) can be used for stimulation of hematopoiesis and specifically upregulation of erythroid production in anemic patients. This is one example of a patent covering compounds that are traditionally seen as in the domain of endocrinologists, that are applied to...

Inventors: Carlino, Joseph A. (San Leandro, CA); Higley, Howard R. (Mountain View, CA); Maack, Christopher A. (El Cerrito, CA)
Assignee: Celtrix Pharmaceuticals
Date of First Priority Issue: Monday September 20th, 1993

Stroma-derived proteoglycan containing composition which promotes differentiation and maintains the self-renewal capacity of long-term bone marrow culture-initiating cells

Patent Number: 5523286

This patent provides a proteoglycan matrix that can be used for growth and expansion of hematopoietic stem cells. Interestingly this patent promotes not just growth of CD34+ hematopoietic stem cells, but specifically, hematopoietic stem cells that are capable of supporting long term cultures. This patent can be used for expanding hematopoietic stem cells for...

Inventors: McGlave, Philip B. (St. Paul, MN); Verfaillie, Catherine M. (St. Paul, MN)
Assignee: Regents of the University of Minnesota (Minneapolis, MN)
Date of First Priority Issue: Friday November 12th, 1993

Three-dimensional pancreatic cell and tissue culture system

Patent Number: 5516681

This patent teaches the use of stromal cells to support growth, proliferation, and differentiation of islet-like pancreatic structures after addition of pancreatic acinar cells to the culture. This technology can be a great basis for the numerous other stem cell technologies currrently available for islet regeneration.

Inventors: Naughton, Gail K. (Groton, VT); Naughton, Brian A. (Groton, VT)
Assignee: Advanced Tissue Sciences, Inc. (La Jolla, CA)
Date of First Priority Issue: Friday April 18th, 1986

Order by:
<< | < | 121 122 123 124 125 126 127 128 129 | > | >>




Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2008 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03